Abstract:Many diseases, as well as side effects of drugs, manifest themselves through skin symptoms. Skin is a complex tissue that hosts various specialized cell types and performs many roles including physical barrier, immune and sensory functions. Therefore, modeling skin in vitro presents technical challenges for tissue engineering. Since the first attempts at engineering human epidermis in 1970s, there has been a growing interest in generating full-thickness skin constructs mimicking physiological functions by incorporating various skin components, such as vasculature and melanocytes for pigmentation. Development of biomimetic in vitro human skin models with these physiological functions provides a new tool for drug discovery, disease modeling, regenerative medicine and basic research for skin biology. This goal, however, has long been delayed by the limited availability of different cell types, the challenges in establishing co-culture conditions, and the ability to recapitulate the 3D anatomy of the skin. Recent breakthroughs in induced pluripotent stem cell (iPSC) technology and microfabrication techniques such as 3D-printing have allowed for building more reliable and complex in vitro skin models for pharmaceutical screening. In this review, we focus on the current developments and prevailing challenges in generating skin constructs with vasculature, skin appendages such as hair follicles, pigmentation, immune response, innervation, and hypodermis. Furthermore, we discuss the promising advances that iPSC technology offers in order to generate in vitro models of genetic skin diseases, such as epidermolysis bullosa and psoriasis. We also discuss how future integration of the next generation human skin constructs onto microfluidic platforms along with other tissues could revolutionize the early stages of drug development by creating reliable evaluation of patient-specific effects of pharmaceutical agents. Impact statement Skin is a complex tissue that hosts various specialized cell types and performs many roles including barrier, immune, and sensory functions. For human-relevant drug testing, there has been a growing interest in building more physiological skin constructs by incorporating different skin components, such as vasculature, appendages, pigment, innervation, and adipose tissue. This paper provides an overview of the strategies to build complex human skin constructs that can faithfully recapitulate human skin and thus can be used in drug development targeting skin diseases. In particular, we discuss recent developments and remaining challenges in incorporating various skin components, availability of iPSC-derived skin cell types and in vitro skin disease models. In addition, we provide insights on the future integration of these complex skin models with other organs on microfluidic platforms as well as potential readout technologies for high-throughput drug screening.

3D Cell Printing of Perfusable Vascularized Human Skin Equivalent Composed of Epidermis, Dermis, and Hypodermis for Better Structural Recapitulation of Native Skin

Direct 3D cell-printing of human skin with functional transwell system

Three-dimensional Bioprinting of a Full-Thickness Functional Skin Model Using Acellular Dermal Matrix and Gelatin Methacrylamide Bioink

3D Cell Printing of in Vitro Stabilized Skin Model and in Vivo Pre-Vascularized Skin Patch Using Tissue-Specific Extracellular Matrix Bioink: A Step Towards Advanced Skin Tissue Engineering

3D bioprinting of skin tissue: From pre-processing to final product evaluation

Simple and robust 3D bioprinting of full-thickness human skin tissue

Vascularization strategies for human skin tissue engineering via 3D bioprinting

Engineering of Diseased Human Skin Equivalent Using 3D Cell Printing for Representing Pathophysiological Hallmarks of Type 2 Diabetes in Vitro.

A biofabricated vascularized skin model of atopic dermatitis for preclinical studies

Advances in 3D skin bioprinting for wound healing and disease modeling

Multicellular bioprinted skin facilitates human-like skin architecture in vivo

Engineering of Uniform Epidermal Layers Via Sacrificial Gelatin Bioink‐Assisted 3D Extrusion Bioprinting of Skin

Three Dimensional Bioprinting of a Vascularized and Perfusable Skin Graft Using Human Keratinocytes, Fibroblasts, Pericytes, and Endothelial Cells

3D Bioprinted Human Skin Model Recapitulating Native‐like Tissue Maturation and Immunocompetence as an Advanced Platform for Skin Sensitization Assessment

Next generation human skin constructs as advanced tools for drug development

3D Bioprinting a Novel Skin Co‐Culture Model Using Human Keratinocytes and Fibroblasts

Incorporation of hair follicles in 3D bioprinted models of human skin

3D bioprinting of skin: a state-of-the-art review on modelling, materials, and processes

Fully Three-Dimensional Bioprinted Skin Equivalent Constructs with Validated Morphology and Barrier Function

Technological advances in three-dimensional skin tissue engineering

Advances in tissue engineering and biofabrication for in vitro skin modeling